Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockade
Year: 2023
Type: conference-abstract
Source: Cancer Research
Authors: Namrata S. Patil, Shyam Srivats, Yoonha Choi, Xiangnan Guan, Barzin Nabet, Lisa McGinnis, Eugene Chiang, Alexis Dunkle, Bill O’Gorman, Patrick S. Chang, Ruozhen Hu, John Silva, Joy Han, Amelia Au-Yeung, Chikara Takahashi, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Raymond Meng, Sanjeev Mariathasan, Robert Johnston, David S. Shames
Institutions: Genentech, Sarah Cannon, Tennessee Oncology, Hospital Universitario Insular de Gran Canaria, Yonsei University, Yonsei University Health System, Yonsei Cancer Hospital, Institut Bergonié, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, Universidad de Navarra, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4362541535
